EAM
MIRM icon

Eventide Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Eventide Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$146M Sell
1,248,389
-160,482
-11% -$16.1M 1.95% 5
2026
Q1 		$130M Sell
1,408,871
-684,711
-33% -$64.4M 2.15% 4
2025
Q4 		$165M Sell
2,093,582
-428,981
-17% -$30.8M 2.58% 3
2025
Q3 		$185M Sell
2,522,563
-114,922
-4% -$7.31M 3.04% 2
2025
Q2 		$134M Buy
2,637,485
+110,485
+4% +$4.92M 2.35% 4
2025
Q1 		$114M Sell
2,527,000
-79,938
-3% -$3.77M 2.27% 4
2024
Q4 		$108M Sell
2,606,938
-838,425
-24% -$34.9M 1.96% 6
2024
Q3 		$134M Sell
3,445,363
-169,457
-5% -$6.76M 2.32% 6
2024
Q2 		$124M Buy
3,614,820
+314,420
+10% +$8.24M 2.12% 8
2024
Q1 		$82.9M Buy
3,300,400
+636,751
+24% +$17.5M 1.3% 25
2023
Q4 		$78.6M Sell
2,663,649
-1,294,930
-33% -$39.2M 1.28% 27
2023
Q3 		$125M Buy
3,958,579
+499,378
+14% +$13.7M 2.25% 7
2023
Q2 		$89.5M Buy
3,459,201
+1,400,000
+68% +$37.2M 1.51% 18
2023
Q1 		$49.5M Buy
2,059,201
+2,201
+0.1% +$50.2K 0.91% 37
2022
Q4 		$40.1M Buy
2,057,000
+782,000
+61% +$15.5M 0.79% 44
2022
Q3 		$26.8M Buy
+1,275,000
New +$30.7M 0.53% 62

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Eventide Asset Management's MIRM Position: Q2 2026 in Review

Eventide Asset Management reduced its Mirum Pharmaceuticals (MIRM) stake by 11% in Q2 2026, selling an estimated $16.1M and leaving 1,248,389 shares worth $146M. The position accounts for 1.95% of the portfolio, ranked #5.

Eventide Asset Management first reported a position in MIRM in Q3 2022 and has held it in 16 quarters since. The position peaked at $185M in Q3 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Eventide Asset Management held 1,248,389 shares of Mirum Pharmaceuticals worth $146M as of Q2 2026.
  • Eventide Asset Management sold 160,482 Mirum Pharmaceuticals shares in Q2 2026, an estimated $16.1M.
  • Mirum Pharmaceuticals made up 1.95% of Eventide Asset Management's portfolio in Q2 2026, its #5 holding.
  • Eventide Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Eventide Asset Management's Mirum Pharmaceuticals position peaked at $185M in Q3 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.